Nicotinamide Riboside dosage

Protocol

1. 1

   Measure the dose

   Typical Nicotinamide Riboside dose is 500 mg. Use a weight-based calculator for individual adjustments.

   Open tool →
2. 2

   Set the frequency

   Administer daily, typically morning. Half-life of 8 hours anchors the dosing interval.

   Open tool →
3. 3

   Cycle if needed

   Continuous use; no formal cycling required

   Open tool →
4. 4

   Monitor for side effects

   Watch for: mild GI upset (rare); headache (rare). Stop or reduce dose if tolerability breaks down.

Why this dose

NAD+ precursor via salvage pathway. Phosphorylated to NMN by nicotinamide riboside kinase (NRK), then converted to NAD+. Substrate for sirtuins, PARPs, and CD38.

The typical 500 mg dose is the figure most commonly used in published protocols for Nicotinamide Riboside. Treat the label as a starting point: body weight, training status, sleep, diet, and concurrent medications all shift the effective dose-response curve in real users.

How to administer

Nicotinamide Riboside is administered via the oral route. Oral dosing is straightforward: take with water, with or without food unless specifically noted.

Onset of action runs around 1 hour after administration. Peak effect lands near 4 hours post-dose. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.

Half-life note: Plasma NR cleared rapidly; downstream NAD+ elevation persists 8-24 hours

Cycling and tolerance

Continuous use; no formal cycling required

Effects to expect at typical dose

• Most-studied NAD+ precursor in human trials; the original Niagen formulation by Chromadex
• Plasma NAD+ rises 30-60% at 250-1,000 mg/day across multiple human PK trials
• Martens 2018 reported reduced BP and arterial stiffness at 500 mg/day for 6 weeks
• Dollerup 2018 found no insulin sensitivity change despite plasma NAD+ rise
• Tissue NAD+ rise inconsistent; hard clinical endpoints not yet measured
• Larger human safety database than NMN; comparable mechanistic effects

Side effects and interactions

Common side effects

• mild GI upset (rare)
• headache (rare)

Notable interactions

• pterostilbene (minor): complementary sirtuin pathway (Basis combination)
• TMG (trimethylglycine) (minor): methylation support during high NAD+ precursor dosing

Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full Nicotinamide Riboside profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.

Regulatory snapshot

WADA status

allowed

DEA / Rx

OTC supplement

Pregnancy

Insufficient data at supplement doses

Legal status

OTC dietary supplement

Do not use if

• pregnancy / lactation (insufficient data)
• active cancer (theoretical, no contraindicating data)

Related research